Literature DB >> 30838291

Levodopa-Carbidopa Intestinal Gel in a Pediatric Parkinsonism-plus Syndrome.

Maria Gabriella Vita1, Francesco Bove1, Paolo Mariotti2, Maria Elena Riccioni3, Vincenzo Leuzzi4, Anna Rita Bentivoglio1,5.   

Abstract

Entities:  

Year:  2017        PMID： 30838291      PMCID： PMC6353485          DOI： 10.1002/mdc3.12509

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  3 in total

1.  Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

Authors:  Holger Honig; Angelo Antonini; Pablo Martinez-Martin; Ian Forgacs; Guy C Faye; Thomas Fox; Karen Fox; Francesca Mancini; Margherita Canesi; Per Odin; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

Review 2.  Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration.

Authors:  Wolfgang H Jost
Journal:  Expert Opin Drug Saf       Date:  2014-03-10       Impact factor: 4.250

3.  Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Authors:  C Warren Olanow; Karl Kieburtz; Per Odin; Alberto J Espay; David G Standaert; Hubert H Fernandez; Arvydas Vanagunas; Ahmed A Othman; Katherine L Widnell; Weining Z Robieson; Yili Pritchett; Krai Chatamra; Janet Benesh; Robert A Lenz; Angelo Antonini
Journal:  Lancet Neurol       Date:  2013-12-20       Impact factor: 44.182
  3 in total
  1 in total

1.  Levodopa-Carbidopa Intestinal Gel in Pediatric Parkinson's Disease.

Authors:  Madison Brooks; Emma Carter; Antonio Quiros; Gonzalo Revuelta
Journal:  Mov Disord Clin Pract       Date:  2020-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.